These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 15232154

  • 1. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Tagg JR.
    Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
    [Abstract] [Full Text] [Related]

  • 2. The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.
    Minami M, Ohmori D, Tatsuno I, Isaka M, Kawamura Y, Ohta M, Hasegawa T.
    FEMS Microbiol Lett; 2009 Sep; 298(1):67-73. PubMed ID: 19594623
    [Abstract] [Full Text] [Related]

  • 3. Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.
    Tagg JR.
    Probiotics Antimicrob Proteins; 2009 Jun; 1(1):60-6. PubMed ID: 26783132
    [Abstract] [Full Text] [Related]

  • 4. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
    Wescombe PA, Upton M, Dierksen KP, Ragland NL, Sivabalan S, Wirawan RE, Inglis MA, Moore CJ, Walker GV, Chilcott CN, Jenkinson HF, Tagg JR.
    Appl Environ Microbiol; 2006 Feb; 72(2):1459-66. PubMed ID: 16461700
    [Abstract] [Full Text] [Related]

  • 5. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.
    Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR.
    Appl Environ Microbiol; 2007 Feb; 73(4):1107-13. PubMed ID: 17194838
    [Abstract] [Full Text] [Related]

  • 6. Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.
    Upton M, Tagg JR, Wescombe P, Jenkinson HF.
    J Bacteriol; 2001 Jul; 183(13):3931-8. PubMed ID: 11395456
    [Abstract] [Full Text] [Related]

  • 7. The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue.
    Dierksen KP, Moore CJ, Inglis M, Wescombe PA, Tagg JR.
    FEMS Microbiol Ecol; 2007 Mar; 59(3):584-91. PubMed ID: 17069620
    [Abstract] [Full Text] [Related]

  • 8. Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?
    Walls T, Power D, Tagg J.
    J Med Microbiol; 2003 Sep; 52(Pt 9):829-833. PubMed ID: 12909662
    [Abstract] [Full Text] [Related]

  • 9. Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.
    Wescombe PA, Dyet KH, Dierksen KP, Power DA, Jack RW, Burton JP, Inglis MA, Wescombe AL, Tagg JR.
    Int J Microbiol; 2012 Sep; 2012():738503. PubMed ID: 22567013
    [Abstract] [Full Text] [Related]

  • 10. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
    Wescombe PA, Burton JP, Cadieux PA, Klesse NA, Hyink O, Heng NC, Chilcott CN, Reid G, Tagg JR.
    Antonie Van Leeuwenhoek; 2006 Oct; 90(3):269-80. PubMed ID: 16871420
    [Abstract] [Full Text] [Related]

  • 11. Effect of administration of Streptococcus salivarius K12 on the occurrence of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media in 3 years old children.
    Di Pierro F, Colombo M, Giuliani MG, Danza ML, Basile I, Bollani T, Conti AM, Zanvit A, Rottoli AS.
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4601-4606. PubMed ID: 27874935
    [Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults.
    Di Pierro F, Adami T, Rapacioli G, Giardini N, Streitberger C.
    Expert Opin Biol Ther; 2013 Mar; 13(3):339-43. PubMed ID: 23286823
    [Abstract] [Full Text] [Related]

  • 13. Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.
    Wescombe PA, Upton M, Renault P, Wirawan RE, Power D, Burton JP, Chilcott CN, Tagg JR.
    Microbiology (Reading); 2011 May; 157(Pt 5):1290-1299. PubMed ID: 21310787
    [Abstract] [Full Text] [Related]

  • 14. Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.
    Barbour A, Philip K.
    PLoS One; 2014 May; 9(6):e100541. PubMed ID: 24941127
    [Abstract] [Full Text] [Related]

  • 15. Positive clinical outcomes derived from using Streptococcus salivarius K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation.
    Di Pierro F, Colombo M, Zanvit A, Rottoli AS.
    Drug Healthc Patient Saf; 2016 May; 8():77-81. PubMed ID: 27920580
    [Abstract] [Full Text] [Related]

  • 16. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media.
    Di Pierro F, Donato G, Fomia F, Adami T, Careddu D, Cassandro C, Albera R.
    Int J Gen Med; 2012 May; 5():991-7. PubMed ID: 23233809
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ.
    J Drugs Dermatol; 2006 Oct; 5(9):868-70. PubMed ID: 17039652
    [Abstract] [Full Text] [Related]

  • 18. Assessment of Efficacy of BLIS-Producing Probiotic K12 for the Prevention of Group A Streptococcus Pharyngitis: a Short Communication.
    Di Pierro F.
    Probiotics Antimicrob Proteins; 2019 Mar; 11(1):332-334. PubMed ID: 29464500
    [Abstract] [Full Text] [Related]

  • 19. Something Old and Something New: An Update on the Amazing Repertoire of Bacteriocins Produced by Streptococcus salivarius.
    Wescombe PA, Heng NC, Burton JP, Tagg JR.
    Probiotics Antimicrob Proteins; 2010 Mar; 2(1):37-45. PubMed ID: 26780899
    [Abstract] [Full Text] [Related]

  • 20. The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius.
    Dempster RP, Tagg JR.
    Arch Oral Biol; 1982 Mar; 27(2):151-7. PubMed ID: 7044350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.